Every week, members of Congress and corporate insiders file the trades they are legally required to disclose. Most of it is routine. Some of it is worth a second look. Here is what landed in the week of September 15, 2026, pulled straight from House and Senate disclosures and SEC Form 4 filings.
Two governor candidates, two different bets
Byron Donalds, the Florida representative running for governor, disclosed a purchase of Netflix (NFLX) in the $1,001 to $15,000 range. Josh Gottheimer, the New Jersey representative running for governor in his own state, went a different direction and bought Applied Materials (AMAT), a semiconductor equipment maker, in the same size range.
Neither trade is large. What makes them worth noting is timing. Both are high-profile names in the middle of active campaigns, and both are on the record buying individual stocks while running for office. If you follow the people, not just the tickers, these are the kind of filings that get attention.
A same-day exit from Google and AbbVie
Pete Sessions of Texas reported selling both Alphabet (GOOGL) and AbbVie (ABBV) on the same day, each in the $15,001 to $50,000 range. Buys get all the headlines, but coordinated same-day sells across two unrelated names are worth a look too. It can mean nothing more than rebalancing. It can also mean someone decided to take chips off the table in two positions at once.
Scott Franklin loaded up on staples and health care
Representative Scott Franklin of Florida filed a cluster of buys on the same trade date, including Accenture (ACN), Novo Nordisk (NVO), and PepsiCo (PEP). A basket of consumer staples and health care names bought together reads more like a defensive positioning move than a single high-conviction bet.
The insider buy of the week: Truist's CEO
On the corporate side, the standout was Truist Financial (TFC). President and CEO Michael Lyons disclosed an open-market purchase of roughly $2.03 million of his own bank's stock. When a sitting CEO reaches into their own pocket at market price for that kind of size, it is one of the cleaner conviction signals in public markets. We broke this one down in its own post.
Why insider buys matter more than sells. Executives sell for a hundred reasons, from taxes to a house to a divorce. They buy for one. They think the stock is going up.
A $22 million foreign buyer in Corebridge
Nippon Life Insurance, the Japanese insurance giant and a major Corebridge Financial (CRBG) shareholder, disclosed a purchase of about $22.5 million. A large strategic buyer scaling an existing position is a different animal than a director buying a few thousand dollars of stock, and it was the largest single insider buy on the tape this week.
Quiet accumulation in energy
Energy showed up in two places. A 10% owner disclosed a purchase of roughly $13.6 million of the United States Oil Fund (USO), and Senator Alan Armstrong reported buying Williams Companies (WMB), a natural gas pipeline operator, more than once in recent weeks. One oil ETF buy and repeat pipeline buys do not make a trend on their own, but sector-level accumulation is the kind of thing worth tracking over a few weeks rather than a few days.
The takeaway
No single filing this week is a reason to trade. That is not how disclosures work. Congress can report up to 45 days after a trade, and insiders file within two business days, so you are always reading the past, not the present. What these filings give you is a running picture of where informed people are putting their own money. Watch the patterns, not the one-offs, and use each name as a starting point for your own read rather than a signal to act on blind.
See every filing as it posts
ChartRead pulls Congress disclosures and SEC Form 4 buys into one free feed, ranked by who actually performs, with a one-tap chart read on each ticker.
📋 Open the Leaderboard